Revolution Medicines Inc (RVMD)
Healthcare
Biotechnology
182.50 $
-2.7%
vs. previous close
Closing price · As of: 3. Aug 2026
Revolution Medicines Inc (RVMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -354 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -67 | -100 | -121 | -161 | -128 | -130 | -138 | -194 | -222 | -207 | -274 | -354 | -1,057 | |
| 1.8 | 2.1 | 2.9 | 2.8 | 2.8 | 0.1 | 3.4 | 3.7 | 3.8 | 4.3 | 33 | 4.5 | 46 | |
| 13 | 14 | 25 | 16 | 20 | 21 | 22 | 25 | 29 | 31 | 34 | 87 | 181 | |
| 8.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 21 | 1.1 | 21 | -47 | -4.7 | 13 | 43 | 2.4 | -4.3 | 56 | 32 | -17 | 67 | |
| 1.1 | 2.5 | 2.3 | 3.2 | 2.4 | 3.5 | 1.2 | 3.3 | 7.5 | 3.3 | 1.9 | 1.5 | 14 | |
| -44 | 77 | -380 | -248 | 108 | -21 | -393 | -16 | 34 | 25 | 75 | 173 | 307 | |
| – | – | 3.3 | – | 3.2 | – | 1.9 | – | 4.6 | – | -1.3 | – | – | |
| 65 | 1.0 | 839 | 0.8 | 7.5 | 77 | 874 | 0.9 | 257 | -1.6 | 366 | 239 | 859 | |
| -46 | -22 | 338 | -408 | -13 | -75 | 342 | -210 | 69 | -184 | 166 | 57 | 109 | |
| -68 | -103 | -123 | -164 | -131 | -134 | -140 | -198 | -229 | -211 | -276 | -356 | -1,072 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.